Ayala Pharmaceuticals Inc (ADXS)

[Traderbx]

ADXS Insider Trades:


Multiple company employees have indulged in significant insider trading. Advaxis, Inc. disclosed in a document filed with the US Securities and Exchange Commission (SEC) that CFO Bonstein Sara has sold 5,520 shares of Advaxis, Inc. (ADXS) in trading session dated Dec. 30, 2016. These shares are worth $40,682 and were traded at $7.37 each. The SEC filing shows that MCKEARN THOMAS J performed a sale of 12,316 shares. The Director disposed these shares by way of transaction on Dec. 20, 2016. The company’s shares were given away at $8.08 per share worth to an income of some $99,513 on account of MCKEARN THOMAS J.

Chief Scientific Officer, PETIT ROBERT, sold 2,797 common shares of Advaxis, Inc. (ADXS) in the open market. In a transaction dated Nov. 02, 2016, the shares were put up for sale at an average price of $8.32, raking in a sum of $23,271. After this sale, 120,744 common shares of ADXS are directly owned by the insider, with total stake valued at $1,058,925.

In the transaction dated Nov. 02, 2016, the great number of shares disposed came courtesy the CEO; O’Connor Daniel disposed a total of 8,240 shares at an average price of $8.32, amounting to approximately $68,557. The insider now directly owns 294,656 shares worth $2,584,133.